Gianmarco Piccinno
Trento, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Resistant starch types 2 and 4 induce distinct and reversible changes in the human gut microbiome.
Journal: Microbiology spectrum
Published: July 24, 2026
Feasibility and Compliance of Stool Collection for Future Microbiome-Based Colorectal Cancer Screening: Preliminary Findings from a Prospective Multicenter FIT-Positive Cohort.
Journal: Microorganisms
Published: June 08, 2026
Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines.
Journal: Research square
Published: November 24, 2025
Advanced computational analysis in metagenomic studies to support precision medicine.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: November 02, 2025
Biodiversity and biogeography of the multi-kingdom cancer microbiome.
Journal: Cell
Published: October 01, 2025
Long-lasting gut microbiome and fecal metabolome alterations after colorectal adenoma removal and their relationship to colorectal cancer.
Journal: Cell host & microbe
Published: September 26, 2025
Strain transmission links human microbiomes along the oral-gut axis and across cohabiting individuals.
Journal: Cell press blue
Published: September 26, 2025
Integrative analyses of dicarbonyls and advanced glycation end-products with multiomic profiles across tissue, plasma and stool samples reveal methylglyoxal accumulation in colon cancer.
Journal: Free radical biology & medicine
Published: September 07, 2025
Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling.
Journal: Nature medicine
Published: August 12, 2025
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial.
Journal: Nature medicine
Published: July 27, 2025
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial.
Journal: Nature medicine
Published: July 24, 2025
Last Updated: 09/26/2026